Friday, April 1, 2016

BRIEF-GlaxoSmithKline says gene therapy for immunodeficiency gets positive CHMP recommendation

* Gsk receives positive CHMP opinion in europe for

Strimvelis, first gene therapy to treat very rare disease,

ADA-SCID

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)